Showing results (71-80 of 215) with videos related to
Sort By:
Pageof 22
Chemmedchem|April 3, 2019
Antibacterial Small Molecules That Potently Inhibit Staphylococcus aureus Lipoteichoic Acid BiosynthesisGeorge A Naclerio, Caroline W Karanja, Clement Opoku-Temeng, et al.Molecular Biosystems|January 17, 2014
E88, a new cyclic-di-GMP class I riboswitch aptamer from Clostridium tetani, has a similar fold to the prototypical class I riboswitch, Vc2, but differentially binds to c-di-GMP analogsYiling Luo, Bin Chen, Jie Zhou, et al.Chemical Communications (Cambridge, England)|August 3, 2012
Nanomolar fluorescent detection of c-di-GMP using a modular aptamer strategyShizuka Nakayama, Yiling Luo, Jie Zhou, et al.Molecular Biosystems|April 6, 2013
Selective binding of 2'-F-c-di-GMP to Ct-E88 and Cb-E43, new class I riboswitches from Clostridium tetani and Clostridium botulinum respectivelyYiling Luo, Jie Zhou, Jingxin Wang, et al.Journal of Proteomics|April 28, 2019
Proteomic analysis of bacterial response to a 4-hydroxybenzylidene indolinone compound, which re-sensitizes bacteria to traditional antibioticsClement Opoku-Temeng, Kenneth Ikenna Onyedibe, Uma K Aryal, et al.Chemical Communications (Cambridge, England)|June 25, 2016
Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small moleculesClement Opoku-Temeng, Jie Zhou, Yue Zheng, et al.RSC Advances|May 13, 2022
Proteomic analysis of RAW macrophages treated with cGAMP or c-di-GMP reveals differentially activated cellular pathwaysMoloud Aflaki Sooreshjani, Ulvi K Gursoy, Uma K Aryal, et al.Analytical Chemistry|February 6, 2014
Unexpected complex formation between coralyne and cyclic diadenosine monophosphate providing a simple fluorescent turn-on assay to detect this bacterial second messengerJie Zhou, David A Sayre, Yue Zheng, et al.Molecules (Basel, Switzerland)|November 13, 2012
Endo-S-c-di-GMP analogues-polymorphism and binding studies with class I riboswitchJie Zhou, David A Sayre, Jingxin Wang, et al.Chemmedchem|November 16, 2023
Identification of a Selective FLT3 Inhibitor with Low Activity against VEGFR, FGFR, PDGFR, c-KIT, and RET Anti-TargetsDesmond Akwata, Allison L Kempen, Neetu Dayal, et al.Pageof 22